Dry powder containing protein powder is not a medicament, to be classified under heading 2106: AAAR
- Blog|News|GST & Customs|
- < 1 minute
- By Taxmann
- |
- Last Updated on 21 June, 2022
Case Details: Appellate Authority for Advance Ruling, Uttarakhand Windlas Biotec Ltd., In re - [2022] 139 taxmann.com 359 (AAAR-UTTARAKHAND)
Judiciary and Counsel Details
-
- P.K. Goel & Dr. Ahmed Iqbal, Member
- Brajesh Gupta, FCA, LLB Adv. for the Applicant.
Facts of the Case
The appellant ventured for manufacture of Dry Powders containing protein powder with vitamins and minerals and it obtained drug license and approval from concerned authorities. It filed an application for advance ruling to determine classification and taxability of product manufactured by it. The Authority for Advance Ruling held that the product manufactured by it would be treated as food supplement and shall be classified under heading 2106. It filed appeal against the order.
AAAR Held
The Appellate Authority for Advance Ruling observed that the product described in label as for prophylactic use but disease or ailment cured or prevented by such product were not mentioned. The impugned product can’t be classified as medicament merely because it would be manufactured under Drug License. The license issued by the Drug Controller may be used as a guide for classification of the product but it can’t be a determining factor. Therefore, the impugned product being in the nature of protein concentrate and manufactured under FSSAI license would be classifiable under heading 2106 and taxable at 18% under GST.
Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.
Taxmann Publications has a dedicated in-house Research & Editorial Team. This team consists of a team of Chartered Accountants, Company Secretaries, and Lawyers. This team works under the guidance and supervision of editor-in-chief Mr Rakesh Bhargava.
The Research and Editorial Team is responsible for developing reliable and accurate content for the readers. The team follows the six-sigma approach to achieve the benchmark of zero error in its publications and research platforms. The team ensures that the following publication guidelines are thoroughly followed while developing the content:
- The statutory material is obtained only from the authorized and reliable sources
- All the latest developments in the judicial and legislative fields are covered
- Prepare the analytical write-ups on current, controversial, and important issues to help the readers to understand the concept and its implications
- Every content published by Taxmann is complete, accurate and lucid
- All evidence-based statements are supported with proper reference to Section, Circular No., Notification No. or citations
- The golden rules of grammar, style and consistency are thoroughly followed
- Font and size that’s easy to read and remain consistent across all imprint and digital publications are applied